Lindsell Train

Biotech and healthcare is leading sector

Taking up non-exec role

Enthusiasm can sometimes get the better of all of us. Investors always find ways to justify prices for companies at any stage in the cycle, writes William Heathcoat-Amory, partner at Kepler Trust Intelligence.

Final column for Investment Week

UK funds ahead

US equity funds also perform well

Runs Finsbury Growth and Income Trust

According to AJ Bell Investcentre

Headwinds and opportunities

Corporate governance improving